Acute Myeloid Leukemia: Evolving Perspectives on Testing, Targeted Therapies, and Transplantation
home / peer-exchange / acute-myeloid-leukemia-evolving-perspectives-on-testing-targeted-therapies-and-transplantation
EP. 19: Maintenance Therapy Post-Transplant in AML
By Harry P. Erba, MD, PhD, Duke University School of Medicine
Alexander E. Perl, MD, University of Pennsylvania
March 15th 2021Alexander E. Perl, MD, University of Pennsylvania
Patient selection for maintenance therapy post-allogeneic transplant in myeloid malignancies and thoughts on treatment of FLT3-mutated disease post-transplant with agents such as midostaurin.
EP. 20: Future Treatment Landscape of AML
By Harry P. Erba, MD, PhD, Duke University School of Medicine
Alexander E. Perl, MD, University of Pennsylvania
March 15th 2021Alexander E. Perl, MD, University of Pennsylvania
Corey S. Cutler, MD, MPH, FRCPC; Adam Bagg, MD; Alexander E. Perl, MD, MS; Eunice S. Wang, MD; and Harry P. Erba, MD, PhD, share closing thoughts and emerging therapies on the horizon for the treatment of AML.
